Journey Medical Corporation (DERM)

USD 4.71

(-2.48%)

Total Debt Summary of Journey Medical Corporation

  • Journey Medical Corporation's latest annual total debt in 2023 was 17.73 Million USD , down -22.8% from previous year.
  • Journey Medical Corporation's latest quarterly total debt in 2024 Q1 was 17.76 Million USD , up 0.21% from previous quarter.
  • Journey Medical Corporation reported annual total debt of 22.96 Million USD in 2022, up 2423.63% from previous year.
  • Journey Medical Corporation reported annual total debt of 910 Thousand USD in 2021, down -83.15% from previous year.
  • Journey Medical Corporation reported quarterly total debt of 22.8 Million USD for 2024 Q2, up 28.36% from previous quarter.
  • Journey Medical Corporation reported quarterly total debt of 23.02 Million USD for 2023 Q1, up 0.24% from previous quarter.

Annual Total Debt Chart of Journey Medical Corporation (2023 - 2014)

Historical Annual Total Debt of Journey Medical Corporation (2023 - 2014)

Year Total Debt Total Debt Growth
2023 17.73 Million USD -22.8%
2022 22.96 Million USD 2423.63%
2021 910 Thousand USD -83.15%
2020 5.4 Million USD 1.87%
2019 5.3 Million USD -98.31%
2018 313.78 Million USD 12.31%
2017 279.38 Million USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 1.93 Million USD 0.0%

Peer Total Debt Comparison of Journey Medical Corporation

Name Total Debt Total Debt Difference
Theratechnologies Inc. 58.96 Million USD 69.933%
Harrow Health, Inc. 190.5 Million USD 90.693%
Dynavax Technologies Corporation 256.91 Million USD 93.099%
Biofrontera Inc. 5.39 Million USD -228.394%
Cronos Group Inc. 2.53 Million USD -598.049%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -2816.118%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 97.522%
Kala Pharmaceuticals, Inc. 36.32 Million USD 51.188%
RedHill Biopharma Ltd. 1.17 Million USD -1411.501%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 3.79%
Radius Health, Inc. 365.31 Million USD 95.147%
Universe Pharmaceuticals INC 5.48 Million USD -223.395%
DURECT Corporation 20.74 Million USD 14.538%
ProPhase Labs, Inc. 21.38 Million USD 17.072%
Safety Shot Inc 1.54 Million USD -1044.629%
Phibro Animal Health Corporation 525.45 Million USD 96.626%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -569.7%
Alvotech 1.07 Billion USD 98.351%
Assertio Holdings, Inc. 40.91 Million USD 56.663%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 57.305%
Rockwell Medical, Inc. 13.43 Million USD -31.929%
Sunshine Biopharma, Inc. 657.7 Thousand USD -2595.737%
Procaps Group S.A. 285.93 Million USD 93.799%
Intra-Cellular Therapies, Inc. 16.93 Million USD -4.676%
SCYNEXIS, Inc. 15.08 Million USD -17.573%
Aytu BioPharma, Inc. 15.12 Million USD -17.192%
Viatris Inc. 18.12 Billion USD 99.902%
OptiNose, Inc. 131.74 Million USD 86.543%
SIGA Technologies, Inc. 1.46 Million USD -1111.058%
Tilray Brands, Inc. 387.31 Million USD 95.422%
PetIQ, Inc. 468.3 Million USD 96.214%
Sunshine Biopharma, Inc. 657.7 Thousand USD -2595.737%
Neurocrine Biosciences, Inc. 428.4 Million USD 95.861%
Guardion Health Sciences, Inc. - USD -Infinity%
Alimera Sciences, Inc. 67.39 Million USD 73.694%
Collegium Pharmaceutical, Inc. 674.28 Million USD 97.371%
Silver Spike Investment Corp. - USD -Infinity%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -1530.054%
Organogenesis Holdings Inc. 119.35 Million USD 85.145%
Petros Pharmaceuticals, Inc. 8.27 Million USD -114.219%
Alpha Teknova, Inc. 30.45 Million USD 41.789%
Clever Leaves Holdings Inc. 2.08 Million USD -749.545%
Lifecore Biomedical, Inc. 130.36 Million USD 86.399%
PainReform Ltd. 86 Thousand USD -20516.279%
Cosmos Health Inc. 12.42 Million USD -42.708%
Avadel Pharmaceuticals plc 35.38 Million USD 49.893%
TherapeuticsMD, Inc. 8 Million USD -121.487%
Embecta Corp. 1.63 Billion USD 98.918%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -29545.359%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 96.975%
Incannex Healthcare Limited 373 Thousand USD -4653.351%
Cyclo Therapeutics, Inc. 1.03 Million USD -1616.169%
Shineco, Inc. 29.65 Million USD 40.215%
Procaps Group, S.A. 285.93 Million USD 93.799%
ANI Pharmaceuticals, Inc. 315.32 Million USD 94.377%
Aquestive Therapeutics, Inc. 98.82 Million USD 82.059%
Lantheus Holdings, Inc. 616.94 Million USD 97.126%
Alvotech 1.07 Billion USD 98.351%
Hempacco Co., Inc. 13.72 Million USD -29.185%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 71.617%
Bright Green Corporation 1.85 Million USD -857.456%
Esperion Therapeutics, Inc. 540.94 Million USD 96.722%
Kamada Ltd. 8.74 Million USD -102.652%
Indivior PLC 281.6 Million USD 93.704%
Evoke Pharma, Inc. 5 Million USD -254.6%
Flora Growth Corp. 3.67 Million USD -382.843%
Cyclo Therapeutics, Inc. 1.03 Million USD -1616.169%
Evolus, Inc. 126.54 Million USD 85.989%
HUTCHMED (China) Limited 86.13 Million USD 79.415%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 97.157%
Akanda Corp. 3.99 Million USD -343.384%